Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) Retained Earnings (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of Retained Earnings data on record, last reported at -$54.1 million in Q3 2019.

  • For Q3 2019, Retained Earnings changed N/A year-over-year to -$54.1 million; the TTM value through Sep 2019 reached -$54.1 million, changed N/A, while the annual FY2018 figure was -$46.0 million, N/A changed from the prior year.
  • Retained Earnings reached -$54.1 million in Q3 2019 per DMAC's latest filing, down from -$51.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $3000.0 in Q1 2019 and bottomed at -$54.1 million in Q3 2019.